1. RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION. (12th June 2019) Authors: Cazelles, C.; Belhadj, K.; Vellemans, H.; Camus, V.; Copi‐Bergman, C.; Veresezan, L.; Itti, E.; Becker, S.; Carvalho, M.; Dupuis, J.; Fabien, L.; Lemonnier, F.; Roulin, L.; El Gnaoui, T.; Jardin, F.; Mounier, N.; Tilly, H.; Haioun, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗